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Abstract
Background: Older people are at increased risk of vitamin B12 deficiency and the provision of fortified foods may
be an effective way to ensure good vitamin B12 status in later life.
Aim: To evaluate the effectiveness of a vitamin B12 fortified food provided by a national program of
complementary food for older people on plasma vitamin B12 levels.
Subjects and methods: A random sub-sample of 351 subjects aged 65-67y from a large cluster randomised
controlled trial provided blood samples at baseline and after 24 months of intervention. The intervention arm (10
clusters 186 participants) received a vitamin B12 fortified food designed to deliver 1.4 μg/day, while the control arm
did not receive complementary food (10 clusters, 165 participants). Serum vitamin B12 and folate levels determined
by radioimmunoassay were used to estimate the effect of intervention on vitamin B12 levels, adjusting for baseline
levels and sex.
Results: Attrition at 24 months was 16.7% and 23.6% in the intervention and control arms respectively (p = 0.07).
Over 24 months of intervention, mean (95% CI) serum vitamin B12 decreased from 392 (359–425) pmol/dL to 357
(300–414) pmol/dL (p < 0.07) in the intervention arm and from 395 (350–440) pmol/dL to 351 (308–395) pmol/dL in
the control arm. There was no significant effect of the intervention on folate status.
Discussion: Our findings suggest that foods fortified with 1.4 μg/daily vitamin B12 as provided by Chile’s national
programme for older people are insufficient to ensure adequate vitamin B12 levels in this population. Chile has a
long and successful experience with nutrition intervention programs; however, the country’s changing
demographic and nutritional profiles require a constant adjustment of the programs.
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Introduction
The ageing process of the Chilean population involve
multiple repercussions on public health [1,2]. The grad-
ual deterioration of physical and mental health condi-
tions that accompanies ageing is a result of genetic and
environmental interactions, including lifestyle, dietary
habits, physical activity, and the presence of disease. Nu-
trition plays an important role in modulating changes in-
duced by aging on various organ and body functions.
Older people are vulnerable to multiple micronutrient
deficiencies, especially vitamin B12 [3].
Vitamin B12 (B12) and folic acid are essential diet-
ary constituents that regulate key metabolic pathways
required for myelin and neurotransmitter synthesis;
they also contribute to red blood cell replication and
maturation [4].
Liver B12 stores are sufficient to meet adult needs for
several months since daily requirements are low (2.4 μg/
day) and manifestations of deficiency are apparent only
after an extended dietary inadequacy (1 to 2 years) [5].
In Chile, the prevalence of B12 deficit in older adults
is high with estimates ranging from 25.4% to 54.1%
[6-8]. The prevalence is greater in men than women [6]
and increases with advancing age [5].
In 1998 the Chilean Ministry of Health established a
program for older adults designed to maintain health
and activity levels in later life, reduce acute morbidity
and functional decline, and decrease health inequalities
[9,10]. The program includes health promotion, illness
prevention, and poverty reduction initiatives [11], and a
complementary feeding program for older people (called
PACAM) [12], which aims to promote adequate nutri-
tion across the life course. Since 1999, PACAM has de-
livered foods to adults over the age of 69 who are
beneficiaries of the National System of Health Services
[13] providing 1.7ug/day of vitamin B12. Since 2000,
wheat flour has been mandatorily fortified in Chile with
2.0-2.4 mg Folic Acid/Kg. Bread is an important food
staple in Chile and this programme is estimated to deliver
200–400 μg of folate per day to older people [14,15].
The primary objective of this study was to evaluate the
effectiveness of the national complementary feeding pro-
gram for older people (PACAM) on serum B12 levels in
older adults. Secondary outcomes of interest include serum
folate levels and relevant haematological parameters.
Subjects and methods
This is a sub-study of the CENEX study [16] which was
a cluster randomised controlled trial design to evaluate
the cost effectiveness of a 2-y nutritional supplementa-
tion (PACAM) and/or physical activity program deliv-
ered at the community level to 2799 eligible subjects
aged 65.0–67.9 y in a factorial design with four distinct
study arms: Nutrition intervention (PACAM) alone,
Exercise alone, Nutrition plus exercise and Control [17].
Exclusion criteria of the CENEX study included unable to
walk unaided, unplanned 3-kg weight loss over 3 months,
planning to move house within 12 months, already en-
rolled in the national PACAM program or reporting a
current consumption of PACAM program supplement
and cognitive impairment defined as a score < 13 using a
19-item Mini Mental State Examination (MMSE) [18] and
scoring < 6 in the PfefferActivities) [19,20].
At baseline, socioeconomic characteristics, history of
chronic diseases and self-reported health status (SRH)
were registered. Anthropometric measurements and phys-
ical performance were assessed as previously described
[17]. A sub-sample of 125 randomly selected participants
per group was invited for the assessment of blood indica-
tors under fasting conditions. Blood samples were
obtained from 491 individuals at baseline and from 394
participants after 2-y of intervention. The CENEX study
was approved by ethics committees at Institute de Nutri-
tion and Technology of Foods (INTA; University of Chile),
Ministry of Health (Government of Chile), and London
School of Hygiene & Tropical Medicine (LSHTM; Univer-
sity of London). All study participants provided full in-
formed written consent before being enrolled in the study.
The intervention comprised 1 kg/month of a dried
soup powdered (made of a mixture of grains and vegeta-
bles) and 1 kg/month of a powdered milk drink (made
of low-lactose milk), both of which were fortified with
vitamins and minerals (Table 1). The recommended daily
dose is 25 g/day of dried soup and 50 g/day powered milk,
both products providing jointly 1.7 ug/day of vitamin B12;
approximately 58% of the daily reference nutrient intake
(2.4 μg/day) [21].
Fasting venous blood sample were collected by study
nurses. All blood samples were stored at −80°C and
processed at the end of the study. The serum B12 and
folate levels were determined in duplicate using radio-
immunoassay (Dual Count Solid phase no boil Assay
Siemens, LA). The red blood cell analysis included
haemoglobin (Hb; g/dL), haematocrit (Hct;%), and median
corpuscle volume (MCV; fL); these parameters were deter-
mined using an electronic particle counter (Cell-Dyn
Model 1700 (Abbott Diagnostics, Abbott Park, IL).
Statistical analysis
We evaluated the groups’ compliance with PACAM intake
by counting the number of PACAM products retrieved
monthly from the health centre, with 12 retrievals consid-
ered 100% compliance (i.e., the collection of 2 kg in 12 of
24 mo), as systematically documented in the records kept
by health centre auxiliary nurses.
The reference values proposed by Allen et al. [22] were
used to categorise B12 status as deficient <148 pmol/dL,
as subclinical deficient with levels between 148 and 221
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pmol/dL, and as normal with levels >221 pmol/dL. We
excluded participants from analysis of B12 status if they
presented with baseline B12 values >680 pmol/L, as
such levels suggest that the participants used vitamin
supplements [23]. For folate, values below 7 nmol/L
were considered deficient, 7 to 46 nmol/L as normal,
and values >46 nmol/L as supraphysiological levels
[23,24]. The diagnosis of anaemia was made for haemo-
globin values <13 g/dL in men and <12 g/dL in women
[7]. Microcytosis and macrocytosis were considered for
values <80 fL and >100 fL, respectively [25].
The five self-reported health status (SRH) response
categories were regrouped into good (excellent, very
good and good) fair and poor.
At baseline and post-intervention, mean (95% CI) or
median (IQR: p25-p75) plasma levels and status (per-
centage, 95% CI) of B12 and folates are reported.
The differences between baseline and post-intervention
mean plasma levels of B12 and folate are reported as mean
differences and 95% CI adjusted for baseline levels and ac-
counting for the clustered design in an intention to treat
analysis. The statistical significance of the differences was
analysed by Wald Test. All statistical analyses were carried
out in STATA 12.0.
Results
From the 491 subjects initially evaluated, 490 blood sam-
ples allowed the measurement of vitamin B12 levels,
from which 351 met the inclusion criterion for plasma
B12 levels <680 pmol/dL: 186 (28% male) in the inter-
vention arm and 165 (30.9% male) in the control arm.
At 24 months, 31 participants from the PACAM group
(16.7%) were lost to attrition, and 39 were lost from the
control group (23.6%) (p = 0.07). A flow diagram is
shown in Figure 1.
Participants collected 68% of total available food and
adherence was 75%. Only one person did not comply at
all and 61,6% complied most of the time.
The baseline characteristics split by arm of interven-
tion and gender are presented in Table 2. The interven-
tion and control arms were well matched for age,
gender, educational attainment, self-perception of health
and haematological parameters at baseline.
In Table 3 baseline and final levels of B12 and folates are
shown, along with the mean and 95%CI of the serum
levels of B12 (pmol/L) and folates (nmol/L) by gender.
B12 levels were significantly lower in men than women,
both in the PACAM group (p = 0.02) and the control
group (p = 0.05). No differences in serum B12 levels at
baseline neither at 24 months were observed between
PACAM and control groups. Serum B12 levels decreased
between baseline and 24 months only in men in both
PACAM (−39.4, p < 0.01) and control (−57.3, p < 0.06). No
difference in the magnitude of the decrease between both
groups was observed.
No differences in serum folate levels at baseline nei-
ther at 24 months were observed between PACAM and
control groups. Serum folates levels decreased signifi-
cantly (p < 0.01) between baseline and 24 months in both
PACAM (−8.3 nmol/L) and control (−7.2 nmol/L)
groups, with no differences in the magnitude of the fall
between both groups.
Table 4 presents B12 and folate status by category and
sex; this shows that the frequency of B12 deficiency was
similar in the two groups at baseline and after interven-
tion. After adjusting for sex, age, and baseline B12, the
multilevel model indicated no significant change in B12
after intervention for either the PACAM or control
groups (data not shown). No folate deficiency at baseline
or post-intervention was observed.
In terms of folate, the prevalence of values >46 nmol/L
was 20.6% at baseline decreasing to 6.8% at 24 months.
After adjusting for sex, age, and baseline folate, the
Table 1 Nutritional composition of fortified foods
Cream soup Milk drink
Nutrient
content per
serving
100 g 1 SERVING
(50 g)
100 g 1 SERVING
(25 g)
% RDA* % RDA*
Energy Kcal 400.0 kcal - 400.0 -
Protein g 13.0 - 18.0 -
lipids g 11.0 - 10.0 -
linoleic acid g - 1.8 -
Carbo-hydrates g 62.3 - 59.5 -
Total dietary fiber g 6.2 - 1.0 -
VITAMINS
Vitamin A (ug RE)1 240.0 15 800.0 25
Vitamin D (ug)2 1.5 15 16.0 80
Vitamin E (mg TE)3 4.0 20 32.0 40
Vitamin C (mg) 30.0 25 180.0 75
Vitamin B1 (mg) 0.35 12.5 0.8 14
Vitamin B2 (mg) 0.40 12.5 1.6 25
Niacin (mg) NE4 4.5 12.5 10.0 14
Vitamin B6 (mg) 1.0 25 1.6 20
Folate (ug) 100.0 25 80.0 10
Vitamin B12 (ug) 1.4 25 2.8 70
MINERALS
Calcium (mg) 400.0 25 1000.0 31
Phosphorus (mg) 400.0 25 800.0 25
Magnesium (mg) 150.0 25 300.0 25
Iron (mg) 5.0 25 5.6 10
Zinc (mg) 6.0 25 12.0 20
*% of Recommended Daily Allowance per the Food Code 1 ug RE = ug retinol
equivalent; 2 ug = ug of cholecalciferol; 3 mg TE =mg tocopherol equivalent;
4 mg NE =mg niacin equivalent.
Quantities expressed per 100 g dry product and per product serving [12].
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multilevel model indicated a significant change in folate
after intervention for either the PACAM or control groups
(data not shown).
The prevalence of anaemia was 8.3% at baseline and
7.5% at 24 months. Macrocytosis was 0.3% at baseline,
increasing to 2.1% after intervention.
Discussion
The results demonstrate that the program did not sig-
nificantly improve B12 status in comparison with the
control group. B12 deficiency is relatively common
among older people and is associated with metabolic,
haematological, cognitive, and neuroconduction prob-
lems [26]. In a study recently published by our group,
we found a B12 deficit of 12% using the cut-off of <148
mpol/L and 25.4% using the cut-off of <221 pmol/L [6].
Allen obtained similar results in an American population
[27] and Loikas in a Turkish population [28].
The possible causes of B12 deficiency in the older
adult population fall into two main categories: a) gastric
atrophy associated with aging, which impedes the ab-
sorption of B12 from foods due to a lack of acid [29,30],
along with decreased levels of intrinsic factor, which is
an essential element for B12 absorption in the ileum;
and b) low intake of B12 containing animal products
[31]. Preliminary data from an on-going study [32] sug-
gest that the intake of B12 from foods in older adults is
on average 5.4 μg/day. The average intake of foods deliv-
ered by PACAM is 25 g/day of powdered milk drink and
3 portions/week of dried soup. Therefore the vitamin
B12 intake provided by the programme is about 0.7 μg/
day, thus resulting in an intake of 6.1 μg/day. Therefore,
considering the recommended daily requirements (2.4
μg/day) for older people it would seem that the defi-
ciency observed in Chile is due primarily to gastric
atrophy.
One of the great challenges in nutrition program de-
sign at a population level is defining the best course of
action for addressing B12 values below the acceptable
limit (148 pmol/L).
Studies of a Latino population residing in the United
States have demonstrated normalised plasma B12 levels
after adding fortified foods or supplements (F/S) >500 μg/
day to the diet. In addition, it has been found that F/S in
the crystalline form of the vitamin is the most effective, as
it is well absorbed by individuals with and without gastric
mucosa atrophy [33].
A possible weakness of this study was that the intake
of PACAM products was not specifically quantitated;
however, considering that the study was an effectiveness
evaluation, no assessment of PACAM intake beyond the
usual controls of the program was considered. Another
potential weakness was not establishing the usual intake
of B12, but Chilean data suggest that the average intake
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Figure 1 Flow-chart for study.
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Table 3 Baseline and post-intervention the vitamin B-12 and folates by group and sex
Vitamin B12 (pmol/L) Folates (nmol/L)
PACAM CONTROL PACAM CONTROL
Baseline 24 months Baseline 24 months Baseline 24 months Baseline 24 months
MEN 52 40 51 40 64 48 66 52
Mean 347.61 307.6 1 374.62 317.22 39.71 31.41 37.92 30.72
(95% CI) (289.2-404.9) (264.7-350.5) (307.8-441.4) (277.7-356.8) (35.7-40.1) (29.3-33.4) (35.7-40.1) (27.7-33.6)
Change -39.4 -57.3 -8.3 -7.2
(95% CI) ((-66.1)-(-12.7)) ((-3.3)-117.9) (-11.5-(-5.2)) (-11.6-(-2.9))
WOMEN 134 115 114 86 180 137 179 137
Mean 407.6 374.3 404.2 367.4 40.31 31.71 39.42 31.12
(95% CI) (377.3-437.8) (308.2-440.4) (354.5-454.0) (314.0-420.7) (37.3-43.4) (29.5-33.9) (36.3-42.5) (29.3-32.8)
Change -33.2 -36.9 -8.6 -8.3
(95% CI) ((-84.5)-18.0) ((-96.6)-22.8) (-13.2-(-4.1)) (-10.9-(-5.7))
TOTAL 186 155 165 126 244 205 245 189
Mean 392.01 357.11 394.8 351.4 40.21 31.61 39.02 30.92
(95% CI) (358.9-425.0) (300.0-414.2) (349.8-439.9) (307.8-395.1) (37.3-43.1) (29.7-33.6) (36.3-41.7) (29.1-32.8)
Change -34.8 -43.4 -8.5 -8.0
(95% CI) ((-73.4)-3.7) ((-97.8)-11.0) (-12.6-(-4.5)) (-10.8-(-5.2))
Vitamin B12 1,2Differences between basal and post-intervention level: 1PACAM: Adjusted Wald Test: Men: p < 0.01; Total p = 0.07; 2CONTROL: Adjusted Wald Test:
Men: p = 0.06. Folates: Differences between basal and post-intervention level: 1Adjusted Wald Test p < 0.01; 2Adjusted Wald Test p = <0.01.
Table 2 Baseline characteristics of study groups
Pacam Control
Men Women Total Men Women Total
n 52 134 186 51 114 165
Age
Median (IQR) 66(65-67) 66(65-67) 66(65-67) 66(65-67) 66(65-67) 66(65-67)
Education
0-5 years% 18.0 34.9 30.1 19.6 33.3 28.9
6-10 years% 38.0 46.8 44.3 51.0 47.2 48.4
>10 years% 44.0 18.2 25.6 29.4 19.4 22.6
Self-reported health status
Good to excellent; n (%) 25(50.0) 57(42.5) 83(44.6) 26(51.0) 45(39.5) 71(43.0)
Fair; n (%) 24(46.1) 69(51.5) 93(51.5) 23(45.1) 60(52.6) 83(50.3)
Poor; n (%) 2(3.9) 8(6.0) 10(5.4) 2(3.9) 9(7.9) 11(6.7)
Vitamin B12 (pmol/L) 337.3 408.0 386.5 355.0 414.8 385.2
Median (IQR) (250.1-438.3) (279.8-535.2) (290.2-524.4) (246.3-474.3) (294.6-576.7) (270.9-513.9)
Folate (nmol/L) 37.2 39.2 39.0 37.4 38.4 37.7
Median (IQR) (33.7-43.7) (32.6-43.7) (32.9-43.7) (29.6-41.1) (32.3-42.6) (31.5-41.7)
Hct (%) 43.7 39.0 40.1 43.7 39.6 40.6
Median (IQR) (41.3-45.3) (37.0-40.7) (37.8-42.6) (41.4-45.8) (37.6-41.3) (38.4-42.6)
Hb (gr/dL) 14.9 13.1 13.5 14.9 13.3 13.7
Median (IQR) (14.0-15.3) (12.6-13.9) (12.8-14.4) (13.8-15.7) (12.6-13.9) (12.9-14.5)
MCV(fL) 90 89 89 89 89 89
Median (IQR) (88-93) (86-91) (87-91) (86-92) (86-91) (86-92)
(IQR: p25-p75).
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Table 4 Vitamin B-12 and folates status before and after intervention, by group and sex
ME WOMEN TOTAL
PACAM Control PACAM Control PACAM Control
% (CI 95%) % (CI 95%) % (CI 95%) % (CI 95%) % (CI 95%) % (CI 95%)
Baseline* 24 months** Baseline* 24 months** Baseline* 24 months** Baseline* 24 months** Baseline* 24 months** Baseline* 24 months**
Vitamin B12 (pmol/L)
n 52 40 51 40 134 115 114 86 186 155 165 126
< 148 13.5 7.5 7.8 7.5 9.0 7.8 7.0 9.3 10.2 7.7 7.3 8.7
(5.1-31.1) (1.8-26.5) (2.9-19.6) (2.6-19.8) (4.8-15.9) (2.9-19.3) (3.2-14.5) (4.2-19.2) (5.9-17.2) (3.4-16.8) (3.6-14.0) (4.5-16.2)
148-221 7.7 15.0 9.8 17.5 6.0 13.9 5.3 16.3 6.4 14.2 6.7 16.7
(4.1-14.0) (9.3-23.4) (4.3-20.8) (9.3-30.4) (3.4-10.2) (9.0-20.8) (3.0-8.9) (9.2-27.2) (5.1-8.1) (9.8-20.2) (3.6-12.0) (11.0-24.4)
222-680 78.8 77.5 82.3 72.5 85.1 72.2 87.7 65.1 83.3 73.5 86.1 67.5
(64.7-88.4) (59.5-89.0) (69.2-90.7) (66.9-77.5) (78.5-89.9) (59.6-82.0) (80.6-92.4) (49.4-78.1) (76.0-88.8) (62.5-82.3) (79.4-90.8) (57.0-76.4)
>680** 0 (0) 2.5 6.1 9.3 4.5 7.1
(0.3-16.8) (2.9-12.1) (4.8-17.1) (2.3-8.6) (3.7-13.3)
Folates (nmol/L)
n 64 48 66 52 180 157 179 137 244 205 245 189
< 7 0 0 0 0 0 0 0 0 0 0 0 0
7-46 79.7 91.7 89.4 90.4 77.2 92.4 77.6 95.6 77.9 92.2 80.8 94.2
(67.8-88.7) (80.0-97.7) (79.4-95.6) (79.0-96.8) (70.4-83.1) (87.0-96.0) (70.8-83.5) (90.7-98.4) (72.1-82.9) (87.6-95.4) (75.3-85.5) (89.8-97.0)
>46 20.3 8.3 10.6 9.6 22.8 7.6 22.3 4.4 22.1 7.8 19.2 5.8
(11.3-32.2) (2.3-20.0) (4.4-20.6) (3.2-21.0) (16.9-29.6) (4.0-13.0) (16.5-29.2) (1.6-9.3) (17.1-27.9) (4.5-12.4) (14.4-24.7) (2.9-10.1)
B12* Test χ2: Men: p = 0.69; Women: p = 0.80; Total p = 0.72. **Test χ2: Men: p = 0.61; Women: p = 0.76; Total p = 0.59. Folates* Test χ2: Men: p = 0.21; Women: p = 0.96; Total p = 0.72. **Test χ2: Men: p = 0.85; Women:
p = 0.25; Total p = 0.55; **High Level excluded analysis baseline.
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of B12 in older adults is above the daily-recommended
allowance.
After the intervention, the folate levels decreased in
both groups, showing that PACAM fortification with
folic acid has little or no effect. Taking into account that
the absorption of folic acid is not influenced by age, and
bread consumption in Chile is very high in all groups of
age, it is possible to postulate that this decrease is due to
a reduction in the amount of folic acid in wheat flour
during the years when the CENEX study was carried
out, as described by Castillo [15].
In Chile, the National Program of Complementary
Feeding for the Elderly over the age of 70 provides
45.8% of the daily-recommended intake of B12. Our
findings show that this amount does not ensure that this
population maintains adequate levels of B12. Therefore,
it is important to address a number of questions regard-
ing the nutritional programs implemented in our coun-
try: First, we should evaluate the true amount of
micronutrients provided by the foods included in these
programs. Second, we should evaluate the effectiveness
of fortifying PACAM products with crystalline B12 in
quantities greater than the RDA. Finally, we should re-
view existing B12 recommendations for this age group.
There is an international consensus on the need to tar-
get B12 in particular in nutrition interventions for older
adults if foods are universally fortified with folic acid [34].
Chile has a long and successful experience in nutrition
intervention programs; however, the country’s changing
demographic, epidemiologic and nutritional profile re-
quires a constant surveillance of the nutritional programs,
carrying out periodic evaluations of the programs’ impact
on the target population.
The high burden of illness associated with chronic
nutrition-related diseases on a global and national level
significantly affects national health budgets. This makes
it even more important to evaluate the interventions and
identify the most cost-effective course of action [35],
without losing sight of the fact that nutrition and phys-
ical activity are fundamental for maintaining an active,
healthy, and autonomous lifestyle and high quality of life
for older adults.
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